Zealand Pharma A/S (CPH: ZEAL)
Denmark
· Delayed Price · Currency is DKK 728.00
-28.50 (-3.77%)
Dec 20, 2024, 4:59 PM CET
Zealand Pharma Cash Flow Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -1,053 | -703.74 | -1,202 | -1,018 | -846.73 | -571.54 | Upgrade
|
| Depreciation & Amortization | 23.11 | 20.12 | 101.57 | 27.82 | 42.69 | 13.68 | Upgrade
|
| Other Amortization | 1.2 | 1.2 | 1.34 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.71 | 4.71 | -0.7 | 6.52 | - | - | Upgrade
|
| Stock-Based Compensation | 76.9 | 61.43 | 52.29 | 53.5 | 30.49 | 14.76 | Upgrade
|
| Other Operating Activities | 4.09 | 138.51 | 81.67 | -130.47 | -12.98 | 122.77 | Upgrade
|
| Change in Accounts Receivable | 162.88 | -6.76 | 26.64 | -64.49 | -7.72 | -21.06 | Upgrade
|
| Change in Inventory | 12.16 | 9.34 | 18.22 | -52.77 | -14.4 | - | Upgrade
|
| Change in Accounts Payable | 30.46 | 39.84 | 21.55 | -49.06 | 119.94 | 17.06 | Upgrade
|
| Change in Other Net Operating Assets | 46.22 | 9.68 | -56.25 | - | - | 14.87 | Upgrade
|
| Operating Cash Flow | -690.82 | -425.67 | -942.31 | -1,212 | -688.72 | -409.46 | Upgrade
|
| Capital Expenditures | -15.6 | -11.24 | -11.71 | -22.13 | -25.04 | -21.04 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.03 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -167.79 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -4.95 | -12.51 | - | - | - | -2.48 | Upgrade
|
| Investment in Securities | -7,456 | -1,070 | 186.58 | - | - | -22.8 | Upgrade
|
| Other Investing Activities | - | - | 106.39 | 4.01 | -3.97 | -5.37 | Upgrade
|
| Investing Cash Flow | -7,477 | -1,094 | 281.26 | -18.12 | -196.81 | -51.67 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 647.91 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -543.43 | -449.81 | -14.72 | -29.22 | -8.69 | Upgrade
|
| Net Debt Issued (Repaid) | 349.38 | -543.43 | -449.81 | 633.19 | -29.22 | -8.69 | Upgrade
|
| Issuance of Common Stock | 8,538 | 1,564 | 1,085 | 775.05 | 832.87 | 697.61 | Upgrade
|
| Repurchase of Common Stock | -351.83 | -41.6 | - | -28.59 | - | - | Upgrade
|
| Other Financing Activities | -237.06 | -71.91 | -47.35 | -46.9 | -42.71 | -14.44 | Upgrade
|
| Financing Cash Flow | 8,299 | 907.01 | 587.5 | 1,333 | 760.94 | 674.48 | Upgrade
|
| Foreign Exchange Rate Adjustments | -4.33 | -7.24 | 13.68 | 66.22 | 3.74 | 7.07 | Upgrade
|
| Net Cash Flow | 126.58 | -619.92 | -59.87 | 168.88 | -120.84 | 220.43 | Upgrade
|
| Free Cash Flow | -706.42 | -436.91 | -954.02 | -1,234 | -713.76 | -430.49 | Upgrade
|
| Free Cash Flow Margin | -918.98% | -127.46% | -917.45% | -1136.94% | -371.75% | -1041.52% | Upgrade
|
| Free Cash Flow Per Share | -11.15 | -7.72 | -20.65 | -28.79 | -18.60 | -12.74 | Upgrade
|
| Cash Interest Paid | 15.97 | 25.25 | 34.12 | 3.3 | 4.56 | 3.39 | Upgrade
|
| Cash Income Tax Paid | - | -11.3 | -9.28 | 41.63 | - | -0.09 | Upgrade
|
| Levered Free Cash Flow | -501.14 | -228.98 | -384.08 | -589.73 | -342.47 | -317.58 | Upgrade
|
| Unlevered Free Cash Flow | -484.01 | -213.78 | -349.29 | -587.18 | -311.65 | -315.57 | Upgrade
|
| Change in Net Working Capital | -133.4 | -78.94 | -16.29 | 153.1 | -38.17 | -46.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.